PARTICIPA

PARTICIPA

lunes, 12 de febrero de 2024

Differential effect of ticagrelor versus clopidogrel by homocysteine levels on risk of recurrent stroke: a post hoc analysis of the CHANCE-2 trial | CMAJ


No hay comentarios:

Publicar un comentario

Danos tu opinion, enriquece el post.